NCT00067158View on ClinicalTrials.gov

Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy - 1

PHASE3CompletedINTERVENTIONAL
Enrollment

585

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

July 31, 2004

Study Completion Date

July 31, 2004

Conditions
Tobacco Use Disorder
Interventions
DRUG

nicotine transdermal system

Trial Locations (13)

10019

St. Luke's Roosevelt Hospital Center, New York

10025

St. Luke's Roosevelt Hospital Center, Womens, New York

10029

Mount Sinai Medical Center, New York

11101

Narco Freedom (Bridge Plaza), Long Island City

28001

Piedmont Behavioral Healthcare, Concord

28412

Coastal Horizons Center, Inc., Wilmington

29671

Behavioral Health Services of Pickens County, Pickens

32805

Center for Drug Free Living, Orlando

33156

SPECTRUM, Miami

48103

Chelsea Arbor Addictions Treatment Center, Ann Arbor

48207

Psychiatry and Behavioral Medicine Professionals I, Detroit

90016

Matrix Institute on Addictions, Los Angeles

91356

Tarzana Treatment Center, Tarzana

All Listed Sponsors
lead

New York University

OTHER

NCT00067158 - Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy - 1 | Biotech Hunter | Biotech Hunter